DCF — ROTHMAN ORTHOPAEDIC SPECIALTY HOSPIT
Enterprise Value: $41.3M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$41.3M
Enterprise Value
$10.5M
PV of Cash Flows
$30.8M
PV of Terminal Value
$49.6M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $66.7M | $5.7M | 9.0% | $1.8M | $1.7M |
| Year 2 | $68.7M | $6.5M | 10.0% | $2.4M | $2.0M |
| Year 3 | $70.8M | $7.4M | 11.0% | $3.0M | $2.3M |
| Year 4 | $72.9M | $8.0M | 11.0% | $3.4M | $2.3M |
| Year 5 | $75.1M | $8.4M | 11.0% | $3.6M | $2.3M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $41.3M. Terminal value accounts for 75% of total EV — typical range (60-80%).
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$64.8M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base0.08000000741091913
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5